Balaji Amines Limited Recommends Annual Dividend; Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019 and Audited Consolidated Earnings Results for the Full Year Ended March 31, 2019
May 15, 2019 at 08:39 am EDT
Share
Balaji Amines Limited recommended the payment of annual dividend of INR 2.80 per equity share 140% on face value of INR 2 per share and the same will be payable after it is approved by the shareholders at the upcoming Annual General Meeting. The record date is July 18, 2019.
The company reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2019 and audited consolidated earnings results for the full year ended March 31, 2019. For the quarter, on standalone basis, the company reported total revenue from operations of INR 2,365.472 million against INR 2,565.971 million a year ago. Net profit for the period was INR 269.980 million or INR 8.33 per basic share against INR 331.760 million or INR 10.24 per basic share a year ago.
For the year, on standalone basis, the company reported total revenue from operations of INR 9,550.501 million against INR 8,653.073 million a year ago. Net profit for the period was INR 1,180.761 million or INR 36.44 per basic share against INR 1,131.810 million or INR 34.93 per basic share a year ago.
For the year, on consolidated basis, the company reported total revenue from operations of INR 9,472.781 million against INR 8,653.073 million a year ago. Net profit for the period was INR 1,170.885 million or INR 36.14 per basic share against INR 1,131.810 million or INR 34.93 per basic share a year ago.
Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals, aliphatic amines and derivatives. The Companyâs segments include Amines & Specialty Chemicals and Hotel Division. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivatives products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL); Di-Ethyl Amine Hydrochloride (DEA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.
Balaji Amines Limited Recommends Annual Dividend; Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019 and Audited Consolidated Earnings Results for the Full Year Ended March 31, 2019